BeiGene, Ltd. (BGNE)
Last Price$226.70.0%
Market Cap$1,846.9M
LTM Free Cash Flow
($1,009.2M)
Reverse DCF (Implied FCF growth)
(100.0%)
3Y Free Cash Flow CAGR
(8.9%)
LTM Revenue
$3,316.8M
Reverse DCF (Implied Revenue growth)
(100.0%)
at normalized FCF margin (42.9%)
3Y Revenue CAGR
46.2%
BGNE Reverse DCF Model
Crunching data... Almost there!
Best stock ideas on the market right now
With Value Sense, you can find undervalued stocks list with intrinsic value. Discover more stock market investment ideas.
BGNE Free Cash Flow
Crunching data... Almost there!
BGNE Growth
Crunching data... Almost there!
BGNE vs Peer Set: Reverse DCF comparison
Crunching data... Almost there!
Explore more intrinsic value tools hub for BGNE
DCF value calculator
Peter Lynch Fair Value
Discount rate
Relative Value
Earnings growth model
Peter Lynch charts
Margin of safety
Intrinsic Value
Earnings Power Value
Ben Graham Fair Value
FAQ
What is BeiGene, Ltd. Reverse DCF (discounted cash flow) valuation?
As of Sep 30, 2024, BeiGene, Ltd.'s Reverse Discounted Cash Flow (DCF) valuation estimates its Free Cash Flow growth at (100.0%).
What is BeiGene, Ltd. WACC?
As of Sep 30, 2024, BeiGene, Ltd.'s Weighted Average Cost of Capital (WACC) is approximately 6.7%.
What is BeiGene, Ltd. Free Cash Flow?
As of Sep 30, 2024, BeiGene, Ltd.'s Free Cash Flow is ($1,009.2M).